Clinical trial
Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma
NCT02585856 is registered in ClinicalTrials.gov with First People's Hospital of Hangzhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma
- Lead sponsor
- First People's Hospital of Hangzhou
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- August 31, 2018
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.